Medinet Co. Ltd. | Balance Sheet

Fiscal year is October-September. All values JPY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
7,681
5,911
3,812
3,594
3,437
2,202
Total Accounts Receivable
361
298
303
359
270
230
Inventories
114
103
98
60
45
49
Other Current Assets
273
284
458
298
301
227
Total Current Assets
8,430
6,596
4,670
4,312
4,053
2,708
Net Property, Plant & Equipment
447
804
1,702
1,470
801
871
Total Investments and Advances
1,687
538
592
433
707
212
Long-Term Note Receivable
630
985
960
607
451
-
Intangible Assets
257
292
321
265
98
79
Other Assets
792
732
652
560
157
67
Total Assets
12,250
9,956
8,910
7,647
6,266
3,937
ST Debt & Current Portion LT Debt
822
829
857
856
54
Accounts Payable
131
111
109
98
77
Income Tax Payable
32
24
23
35
20
Other Current Liabilities
296
323
267
257
236
Total Current Liabilities
1,281
1,286
1,257
1,246
388
Long-Term Debt
48
50
144
182
73
Provision for Risks & Charges
-
73
213
210
207
Deferred Taxes
471
56
96
67
111
Other Liabilities
73
3
14
10
6
Total Liabilities
1,880
1,476
1,737
1,715
786
Common Equity (Total)
10,370
8,479
7,173
5,931
5,480
Total Shareholders' Equity
10,370
8,479
7,173
5,931
5,480
Total Equity
10,370
8,479
7,173
5,931
5,480
Liabilities & Shareholders' Equity
12,250
9,956
8,910
7,647
6,266

About Medinet Co.

View Profile
Address
Shin-Yokohama Square Building, 14/F
Yokohama Kanagawa 222
Japan
Employees -
Website http://www.medinet-inc.co.jp
Updated 07/08/2019
MEDINET Co., Ltd. engages in cell processing business. It offers solutions for regenerative medicine and cell therapy value chain through preclinical research, development, manufacturing and commercial launch. It operates through the Cell Processing and Regenerative Medical Products segments.